Showing results (41-50 of 292) with videos related to
Sort By:
Pageof 30
Expert Opinion on Pharmacotherapy|March 23, 2007
Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary diseaseSteven Simoens, Marc DecramerPharmacy World & Science : PWS|July 8, 2005
Applying health technology assessment to pharmaceutical care: pitfalls and future directionsSteven Simoens, Gert LaekemanSeminars in Thrombosis and Hemostasis|December 14, 2012
Market entry of biosimilar low-molecular-weight heparins in Europe: opportunities and challengesSteven Simoens, Isabelle HuysFrontiers in Pharmacology|February 18, 2021
Guidance for Demonstrating the Societal Value of new AntibioticsSteven Simoens, Isabel SprietApplied Health Economics and Health Policy|February 11, 2005
The impact of physician payment methods on raising the efficiency of the healthcare system: an international comparisonSteven Simoens, Antonio GiuffridaExpert Opinion on Pharmacotherapy|June 24, 2008
A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacinSteven Simoens, Marc DecramerInternational Immunopharmacology|May 17, 2011
Kiovig for primary immunodeficiency: reduced infusion and decreased costs per infusionMark Connolly, Steven SimoensExpert Opinion on Biological Therapy|November 18, 2020
A health economic guide to market access of biosimilarsSteven Simoens, Arnold G VultoCardiovascular Drugs and Therapy|October 24, 2013
Patient co-payment and adherence to statins: a review and case studiesSteven Simoens, Peter R SinnaeveCardiovascular Drugs and Therapy|December 18, 2012
Generic atorvastatin, the Belgian statin market and the cost-effectiveness of statin therapySteven Simoens, Peter R SinnaevePageof 30